SeaStar Medical Statistics
Share Statistics
SeaStar Medical has 402.72M shares outstanding. The number of shares has increased by null% in one year.
| Shares Outstanding | 402.72M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Institutions (%) | n/a |
| Shares Floating | - |
| Failed to Deliver (FTD) Shares | - |
| FTD / Avg. Volume | -% |
Short Selling Information
The latest short interest is 0, so 0% of the outstanding shares have been sold short.
| Short Interest | 0 |
| Short % of Shares Out | 0% |
| Short % of Float | 0% |
| Short Ratio (days to cover) | 0 |
Valuation Ratios
The PE ratio is -0.37 and the forward PE ratio is null.
| PE Ratio | -0.37 |
| Forward PE | null |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | -0.69 |
| P/FCF Ratio | -0.93 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for SeaStar Medical.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.18, with a Debt / Equity ratio of -0.65.
| Current Ratio | 0.18 |
| Quick Ratio | 0.18 |
| Debt / Equity | -0.65 |
| Total Debt / Capitalization | -189.62 |
| Cash Flow / Debt | -1.13 |
| Interest Coverage | -13.15 |
Financial Efficiency
Return on equity (ROE) is 1.89% and return on capital (ROIC) is 296.72%.
| Return on Equity (ROE) | 1.89% |
| Return on Assets (ROA) | -7.47% |
| Return on Capital (ROIC) | 296.72% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -2.19M |
| Employee Count | 12 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by null% in the last 52 weeks. The beta is -1.06, so SeaStar Medical's price volatility has been lower than the market average.
| Beta | -1.06 |
| 52-Week Price Change | null% |
| 50-Day Moving Average | 0.03 |
| 200-Day Moving Average | 0.06 |
| Relative Strength Index (RSI) | 51.16 |
| Average Volume (20 Days) | - |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -14.21M |
| Net Income | -26.23M |
| EBITDA | -11.14M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -30.29 |
Balance Sheet
The company has 176.00K in cash and 9.08M in debt, giving a net cash position of -8.90M.
| Cash & Cash Equivalents | 176.00K |
| Total Debt | 9.08M |
| Net Cash | -8.90M |
| Retained Earnings | -114.73M |
| Total Assets | 4.59M |
| Working Capital | -3.02M |
Cash Flow
In the last 12 months, operating cash flow was -10.29M and capital expenditures 0, giving a free cash flow of -10.29M.
| Operating Cash Flow | -10.29M |
| Capital Expenditures | 0 |
| Free Cash Flow | -10.29M |
| FCF Per Share | -11.88 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ICUCW does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for ICUCW.
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
Scores
| Altman Z-Score | -64.06 |
| Piotroski F-Score | 6 |